FDA recall record

RAYSEARCH LABORATORIES AB RayStation 4.5, 4.7, 4.9, 5, 6, 7, 8A, 8B, 9A, 9B, 10A, 10B recall — FDA Z-1597-2021

For some LINAC types, merging clinical beams with beams of approximate dose may lead to the approximate dose erroneously labeled as clinical dose. Merge…

Class IIclassification
Z-1597-2021official record ID
May 26, 2021report date

Recall record at a glance

Official recordZ-1597-2021
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmRAYSEARCH LABORATORIES AB
Report dateMay 26, 2021
Recall initiation dateFeb 22, 2021
Quantity116 units
LocationStockholm, N/A, Sweden

Official product description

RayStation 4.5, 4.7, 4.9, 5, 6, 7, 8A, 8B, 9A, 9B, 10A, 10B, RayPlan 1, 2, 7, 8A, 8B, 9A, 10A, 10B including some of the Service Packs. Standalone software treatment planning system

Why the product was recalled

For some LINAC types, merging clinical beams with beams of approximate dose may lead to the approximate dose erroneously labeled as clinical dose. Merge beams can be used manually, in scripting, or as part of the Automated breast planning feature. In some cases, when merging two beams where the first beam has clinical dose and the second beam has approximate dose, the dose of the resulting beam will be labeled as Clinical, although dose for some of the beam segments is still calculated with the SVD dose engine and it should be labeled Approximate: Mixed dose. The difference between approximate and final Clinical dose is in most cases small, but there can be body sites such as lung where the difference can be significant.

Distribution information

US Nationwide distribution.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: E-Mail.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

Medical DeviceJan 28, 2026

RayStation recall — FDA Z-1110-2026

Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and…

Class IIFDA: OngoingRAYSEARCH LABORATORIES AB
Medical DeviceJan 28, 2026

RayStation recall — FDA Z-1106-2026

Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and…

Class IIFDA: OngoingRAYSEARCH LABORATORIES AB
Medical DeviceJan 28, 2026

RayStation recall — FDA Z-1108-2026

Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and…

Class IIFDA: OngoingRAYSEARCH LABORATORIES AB
Medical DeviceJan 28, 2026

RayStation recall — FDA Z-1109-2026

Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and…

Class IIFDA: OngoingRAYSEARCH LABORATORIES AB